FORCED DEGRADATION STUDY OF STATINS: A REVIEW


Rini Yulianita, Iyan Sopyan, Muchtaridi Muchtaridi

Abstract


Forced degradation study is the degradation of new drug substances and drug products in more severe conditions than accelerated conditions. Forced degradation study were conducted to demonstrate the specificity of stability-indicating methods, providing insight into degradation pathways and drug degradation products, assisting in the elucidation of degradation product structures, identifying degradation products that could be spontaneously generated during storage and use of drugs and to facilitate improvement in manufacturing process and formulation corresponding with accelerated stability studies. Statins, a class of lipid-lowering medications, are the most widely prescribed drugs and an example of an unstable drug. Statins are susceptible to hydrolysis in the presence of high temperatures and humidity. Therefore, the review discusses various studies of forced degradation studies in six statins drug (atorvastatin, fluvastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin) to describe the drug's intrinsic stability thus it can assist the selection of formulations and packaging as well as proper storage conditions.


Keywords


Forced degradation study, Stress testing, Drugs stability, Statins

References


Singh S, Junwal M, Modhe G, Kurmi M, Parashar N, Sidduri P. Forced degradation studies to assess the stability of drugs and products. Trends Anal Chem. 2013;1-41

ICH Expert Working Group. ICH guideline Q1A (R2): Stability testing of new drug substances and products. Int Conf Harmon. 2003;24.

Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs — A review. J Pharm Anal. 2014;4:159-65.

Jenke DR. Chromatographic method validation : A review of current practices and procedures. II. Guidelines for primary validation parameters. J Liq Chromatogr. 1996;19:737–57.

Ferenczi-Fodor K, Végh Z, Renger B. Impurity profiling of pharmaceuticals by thin-layer chromatography. J Chromatogr A. 2011;1218:2722-31.

Bakshi, M, Singh S. Development of validated stability-indicating assay methods – Critical review. J Pharm Biomed Anal. 2002;28:1011–40.

Davidson MH. Rosuvastatin : A highly efficacious statin for the treatment of dyslipidemia. Expert Opin Investig Drugs. 2002;11:125-41.

Petyaev IM. Improvement of hepatic bioavailability as a new step for the future of statin. Arch Med Sci. 2015;11:406-10.

Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins : An update. Fundam Clin Pharmacol. 2004;19:117-25.

Sanjaymitra PVSS, Ganesh GNK. Dissolution and solubility enhancement strategies : Current and novel prospectives. J Crit Rev. 2018;5:1-10

Gupta D, Mandowara V, Patel S, Shelat P. Improvement of efficacy and safety profile of simvastatin in comparison to reference product (Zocor tablets) using nanoparticulate formulation approach. Int J Curr Pharm Res. 2016;8:39-47.

Reddy KVR, Nagabhushanam M V. The role of needle in formulation of pH-sensitive swellable microbeads prepared with hydrophilic polymers for atorvastatin and their characterization studies. Int J Appl Pharm. 2017;9:20-30.

Dayyih WAABU, Mallah EM, Al-Ani IH, Arafat TA. Liquorice beverage effect on the pharmacokinetic parameters of atorvastatin, simvastatin, and lovastatin by liquid chromatography-mass spectroscopy/mass spectroscopy. Asian J Pharm Clin Res. 2016;9:174-9.

Alvarez-Lueje A, Valenzuela C, Squella JA, Núñez-Vergara LJ. Stability study of simvastatin under hydrolytic conditions assessed by liquid chromatography. J AOAC Int. 2005;88:1631-6.

Jemal, M., Zheng O., Powell ML. Direct-injection LC–MS–MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasma. J Pharm Biomed Anal. 2000;23:323-40.

Shah RP, Kumar V, Singh S. Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation products. Rapid Commun Mass Spectrom. 2008;22:613-22.

Kadav AA, Vora DN. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate, and their degradation products in tablets. J Pharm Biomed Anal. 2008;48:120-6.

Vora DN, Kadav AA. Validated ultra HPLC method for the simultaneous determination of atorvastatin, aspirin, and their degradation products in capsules. J Liq Chromatogr Relat Technol. 2008;31:2821-37.

Kumar KK, Rao CK. A validated stability indicating RP-UPLC method for atorvastatin calcium. Am J Anal Chem. 2012;3:392-9.

Vukkum P, Abu JMOB, Uralikrishna RM. Stress degradation behavior of atorvastatin calcium and development of a suitable stability-indicating LC method for the determination of atorvastatin, its related impurities, and its degradation products. Sci Pharm. 2013;81:93-114.

Gite S, Patravale V. Validation of RP-HPLC method and stress degradation for the combination of metformin HCl, atorvastatin calcium, and glimepiride : Application to nanoparticles. J Chromatogr Sci. 2015:1-9.

Singh S, Dahiya R. Stability-indicating RP-HPLC method for estimation of atorvastatin calcium in solid dosage form. Bull Pharm Res. 2014;4:9-13.

Sathiyasundar KVR. New stability indicating assay method by liquid chromatographic separation of aspirin, atorvastatin, and clopidogrel in pharmaceutical dosage form. Indo Am J Pharm Res. 2014;4:5919-27.

Oliveira MA, Yoshida MI, Belinelo VJ, Valotto RS. Degradation kinetics of atorvastatin under stress conditions and chemical analysis by HPLC. 2013;18:1447-56.

Lakka NS, Goswami N, Balakrisna VSP. Development and validation of a stability-indicating RP-HPLC for the simultaneous determination of atorvastatin calcium and simvastatin in pharmaceutical solid dosage forms. Int J Res Pharm Sci. 2011;2:608-15.

Aiyalu R, Mani K. HPTLC method development, validation, and stress degradation studies for atorvastatin and ezetimibe in multicomponent tablet dosage form. Med Chem Res. 2012;21:1297-301.

Goel A, Baboota S, Sahni JK, et al. Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe. J Chromatogr Sci. 2013;51:222-8.

S Naidu P, S Durga, R Baby Nalanda, Bolla N, Atla SR. A validated stability indicating RP-HPLC method for the simultaneous determination of atorvastatin calcium and ezetimibe hydrochloride in bulk and tablet dosage form. Int J Pharm Pharm Sci. 2016;8:370-7.

Akabari AH, Suhagia BN, Saralai MG, Sutariya VA. Development and validation of stability indicating RP- HPLC method for estimation of fluvastatin sodium in bulk and capsule dosage form. Eurasian J Anal Chem. 2017;12:87-105.

Gomes FP, Garcia PL, Alves JMP, Singh AK, Kedor-Hackmann ERM, Santoro MIRM. Development and validation of stability-indicating HPLC methods for quantitative determination of pravastatin, fluvastatin, atorvastatin, and rosuvastatin in pharmaceuticals. Analytical Letters. 2009;42:1784-804.

Aglawe KV, Kharat UP, Dongaonkar CC, Chavan VA. Development and validation of stability indicating UV spectrophotometric method for the determination of pitavastatin calcium. World J Pharmacy Pharm Sci. 2016;5:1773-87.

Akabari AH, Shah DR, Shah SA, Suhagia BN. Kinetic determinations of pitavastatin calcium by stability indicating HPTLC method. J Liq Chromatogr Relat Technol. 2015;38:521-31.

Damle MC, Polawar AR. Stability indicating HPTLC method for the estimation of pitavastatin calcium in presence of acid-induced degradation product. Int J ChemTech Res. 2014;6:2824-33.

H.J. Panchal BNS. Stability-indicating liquid chromatographic method for analysis of pitavastatin calcium in tablet dosage forms. Acta Chromatogr. 2011;23:81-94.

Sujatha, K, Seshagiri Rao JVLN. A new validated stability-indicating RP-HPLC method for the estimation of pitavastatin in tablet dosage forms. Int J Pharm Anal Res. 2014;3:67-73.

Onal, A, Sagirli O. Development of a selective LC method for the determination of pravastatin sodium. Chromatographia. 2006;64:157-62.

Athota RV, Jagarlapudi SK, Singampalli MR. Stability indicating HPLC method for the simultaneous quantification of aspirin and pravastatin in bulk and tablets : Method development and validation. J Appl Pharm Sci. 2017;7:48-56.

A. Ahmad, B.P. Panda, Mujeeb M. A validated stability-indicating method for simultaneous analysis of mevastatin and pravastatin in fermentation broth during bioconversion by Actinomadura macra. Acta Chromatogr. 2011;23:121-31.

Reddy GR, Reddy PR, Jyothi PS. Development of a stability-indicating stereoselective method for quantification of the enantiomer in the drug substance and pharmaceutical dosage form of rosuvastatin calcium by an enhanced approach. Sci Pharm. 2015;83:279-96.

Venkat G, Reddy R, Reddy BV, Haque SW, Gautam HD, Kumar P. Development and validation of a stability-indicating UPLC method for rosuvastatin and its related impurities in pharmaceutical dosage forms. Quim Nov. 2011;34:250-5.

Mostafa NM, Badawey AM, Lamie NT, El-Aleem EBA. Selective chromatographic methods for the determination of rosuvastatin calcium in the presence of its acid degradation. J Liq Chromatogr Relat Technol. 2014;37:2182-96.

Badawy AMRM, Mostafa NM, El ABD, Abd AB, Aleem EL, Lamie NT. Stability ­indicating PLS and PCR chemometric methods for the determination of rosuvastatin in presence of its two oxidative degradation products. Int J Pharm Pharm Sci. 2011;3:232-7.

Trivedi, HK, Patel MC. Development and validation of a stability-indicating RP-UPLC method for determination of rosuvastatin and related substances in pharmaceutical dosage form. Sci Pharm. 2012;80:393-406.

Shah RP, Sahu A, Singh S. LC-MS/TOF, LC-MS, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products : A comprehensive approach during drug development. Anal Bioanal Chem. 2013;405:3215-31.

Ashfaq M, Akhtar T, Mustafa G, Danish M, Naeem S, Nazar MF. Simultaneous estimation of rosuvastatin and amlodipine in pharmaceutical formulations using stability indicating HPLC method. Brazilian J Pharm Sci. 2014;50:629-36.

Mukthinuthalapati MA, Bukkapatnam V, Pavan S, Bandaru K. Stability indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe in pharmaceutical formulations. Adv Pharm Bull. 2014;4:405-11.

Belal F, Ibrahim F, Khedr A, Elawady T. Stability indicating TLC method for the determination of rosuvastatin and identification of some degradation products using electrospray ionization mass spectrometry. 2014;37:1114-32.

Kapuganti ANK, Gandhi BM, Raju VB, Sumanth KS, Kagitapurapu VK, Srinivas K, Harika P. Development and validation of stability indicating RP-HPLC method for simultaneous estimation of ramipril, aspirin, and simvastatin in bulk and pharmaceutical dosage form. Asian J Biomed Pharm Sci. 2016;6:14-20.

El Karbane M , Azougagh M, Al Kamarany MA, Bouchafra H, Cherrah Y, Bouklouze A. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin, and its impurities in tablet dosage forms. Ann Pharm Fr. 2014:72:244-55.

Kumar P, Chakraborthy GS. Stability indicating RP-HPLC method development for determination of simvastatin in dosage forms. World J Pharm Sci. 2014;3:1189-205.

Rao KLN, Krishnaiah C, Reddy KP. Stability-indicating liquid chromatographic method for the simultaneous determination of ascorbic acid, citric acid, butylated hydroxyanisole, simvastatin, and related compounds in pharmaceutical solid dosage form. Int J Analytical, Pharm Biomed Sci. 2014;3:1-10.

Devu S, Gupta A, Srinivas KS, Gupta RS, Semwal VP. Chromatography development and validation of stability indicating RP-UPLC method for simultaneous determination in fixed dose combination of ezetimibe and simvastatin. J Chromat Separation Techniq. 2012;3:1-7.

Gomes FP, García PL, Alves JMP, Singh AK, Kedor-Hackmann ERM, Santoro MIRM. UV-derivative spectrophotometric and stability-indicating high-performance liquid chromatographic methods for determination of simvastatin in tablets. Lat Am J Pharm. 2009;28:261-9.

Silva TD, Oliveira MA, Oliveira RB De, Vianna-Soares CD. Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin, and simvastatin. J Chromatogr Sci. 2012;50:831-8.

Ghodke SS. Stability indicating RP-HPLC method for simvastatin and sitaglipin phosphate with degradation studies in marketed pharmaceutical hypo-cholesterol and antidiabetic tablets. Int J Pharm Chem Biol Sci. 2018;8:99-109.

Chavhan V, Ghante M. Stability indicating UV spectrophotometric method development and validation of simvastatin in bulk and tablet dosage form. J Appl Pharm. 2014;6:235-46.

Sawant S, Ghante M. A validated stability indicating RP-HPLC method for simvastatin, identification and characterization of forced degradation products of simvastatin using LC-ESI-MS/MS. Adv Anal Chem. 2015;5:8-16.

Malenovic A, Jancic-Stojanovic B, Ivanovic D, Medenica M. Forced degradation studies of simvastatin using microemulsion liquid chromatography. J Liq Chromatogr Relat Technol. 2010;33:536-47.

Nalaiya J, Sagineedu SRAO, Rajasingam R, Kassim Z, Pichika MRAO. A stability-indicating RP-HPLC method for simultaneous determination of simvastatin and niacin in a combined dosage form. Int J Pharm Pharm Sci. 2015;7:262-8.




Fatal error: Call to a member function getGalleyLabel() on null in /home/innowar1/public_html/journals/cache/t_compile/%%38^38D^38D7420B%%article.tpl.php on line 182